BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30228286)

  • 1. Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.
    Belužić L; Grbeša I; Belužić R; Park JH; Kong HK; Kopjar N; Espadas G; Sabidó E; Lepur A; Rokić F; Jerić I; Brkljačić L; Vugrek O
    Sci Rep; 2018 Sep; 8(1):14012. PubMed ID: 30228286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells.
    Pavičić I; Rokić F; Vugrek O
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
    Uchiyama N; Tanaka Y; Kawamoto T
    Eur J Pharmacol; 2017 Oct; 812():138-146. PubMed ID: 28705714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency.
    Stender S; Chakrabarti RS; Xing C; Gotway G; Cohen JC; Hobbs HH
    Mol Genet Metab; 2015 Dec; 116(4):269-74. PubMed ID: 26527160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of AHCY inhibitors using novel high-throughput mass spectrometry.
    Uchiyama N; Dougan DR; Lawson JD; Kimura H; Matsumoto SI; Tanaka Y; Kawamoto T
    Biochem Biophys Res Commun; 2017 Sep; 491(1):1-7. PubMed ID: 28533090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase.
    Matthews RP; Lorent K; Mañoral-Mobias R; Huang Y; Gong W; Murray IV; Blair IA; Pack M
    Development; 2009 Mar; 136(5):865-75. PubMed ID: 19201949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AHCY impedes proliferation and differentiation of mouse and human adipocyte progenitor cells.
    Boczki P; Colombo M; Weiner J; Rapöhn I; Lacher M; Kiess W; Hanschkow M; Körner A; Landgraf K
    Adipocyte; 2024 Dec; 13(1):2290218. PubMed ID: 38064408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.
    Akpa CA; Kleo K; Oker E; Tomaszewski N; Messerschmidt C; López C; Wagener R; Oehl-Huber K; Dettmer K; Schoeler A; Lenze D; Oefner PJ; Beule D; Siebert R; Capper D; Dimitrova L; Hummel M
    BMC Cancer; 2020 May; 20(1):427. PubMed ID: 32408898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in S-adenosylhomocysteine hydrolase (AHCY) affect its nucleocytoplasmic distribution and capability to interact with S-adenosylhomocysteine hydrolase-like 1 protein.
    Grbeša I; Kalo A; Belužić R; Kovačević L; Lepur A; Rokić F; Hochberg H; Kanter I; Simunović V; Muńoz-Torres PM; Shav-Tal Y; Vugrek O
    Eur J Cell Biol; 2017 Sep; 96(6):579-590. PubMed ID: 28647132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.
    Park SJ; Kong HK; Kim YS; Lee YS; Park JH
    Am J Cancer Res; 2015; 5(7):2127-38. PubMed ID: 26328244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Turkish patient with novel AHCY variants and presumed diagnosis of S-adenosylhomocysteine hydrolase deficiency.
    Bas H; Cilingir O; Tekin N; Saylisoy S; Durak Aras B; Uzay E; Erzurumluoglu Gokalp E; Artan S
    Am J Med Genet A; 2020 Apr; 182(4):740-745. PubMed ID: 31957987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of AHCY may increase the risk of ischemic stroke.
    Zhao L; Chen X; Zhou S; Lin Z; Yu X; Huang Y
    Bosn J Basic Med Sci; 2020 Nov; 20(4):471-476. PubMed ID: 32020847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-adenosylhomocysteine hydrolase (AHCY) deficiency: two novel mutations with lethal outcome.
    Vugrek O; Beluzić R; Nakić N; Mudd SH
    Hum Mutat; 2009 Apr; 30(4):E555-65. PubMed ID: 19177456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic perturbation of epigenome by inhibiting S-adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells.
    Wu G; Wang N; Luo Y; Zhang Y; Wang P; Zhu Z; Gao Y; Du Z; Yang B
    Tumour Biol; 2017 May; 39(5):1010428317699117. PubMed ID: 28459194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma.
    Pogribny IP; Dreval K; Kindrat I; Melnyk S; Jimenez L; de Conti A; Tryndyak V; Pogribna M; Ortega JF; James SJ; Rusyn I; Beland FA
    FASEB J; 2018 Mar; 32(3):1591-1601. PubMed ID: 29127188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation.
    Sivertsson L; Edebert I; Palmertz MP; Ingelman-Sundberg M; Neve EP
    Mol Pharmacol; 2013 Mar; 83(3):659-70. PubMed ID: 23264496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
    Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
    Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.